Afya Ltd (AFYA)vsCovista Inc. (CVSA)
AFYA
Afya Ltd
$10.17
-0.68%
CONSUMER DEFENSIVE · Cap: $1.29B
CVSA
Covista Inc.
$128.76
+1.79%
CONSUMER DEFENSIVE · Cap: $4.46B
Smart Verdict
WallStSmart Research — data-driven comparison
Afya Ltd generates 96% more annual revenue ($3.83B vs $1.95B). AFYA leads profitability with a 20.4% profit margin vs 12.9%. AFYA trades at a lower P/E of 8.9x. CVSA earns a higher WallStSmart Score of 71/100 (B).
AFYA
Strong Buy66
out of 100
Grade: B-
CVSA
Strong Buy71
out of 100
Grade: B
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+73.5%
Fair Value
$58.62
Current Price
$10.17
$48.45 discount
Intrinsic value data unavailable for CVSA.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Reasonable price relative to book value
Strong operational efficiency at 30.6%
Keeps 20 of every $100 in revenue as profit
Safe zone — low bankruptcy risk
Growing faster than its price suggests
Attractively priced relative to earnings
Earnings expanding 43.2% YoY
Areas to Watch
Smaller company, higher risk/reward
No major concerns identified
Comparative Analysis Report
WallStSmart ResearchBull Case : AFYA
The strongest argument for AFYA centers on P/E Ratio, Price/Book, Operating Margin. Profitability is solid with margins at 20.4% and operating margin at 30.6%.
Bull Case : CVSA
The strongest argument for CVSA centers on Altman Z-Score, PEG Ratio, P/E Ratio. PEG of 0.93 suggests the stock is reasonably priced for its growth.
Bear Case : AFYA
The primary concerns for AFYA are Market Cap.
Bear Case : CVSA
No major red flags identified for CVSA, but monitor valuation.
Key Dynamics to Monitor
AFYA profiles as a mature stock while CVSA is a value play — different risk/reward profiles.
CVSA carries more volatility with a beta of 0.65 — expect wider price swings.
CVSA is growing revenue faster at 9.7% — sustainability is the question.
AFYA generates stronger free cash flow (173M), providing more financial flexibility.
Bottom Line
CVSA scores higher overall (71/100 vs 66/100). AFYA offers better value entry with a 73.5% margin of safety. Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Afya Ltd
CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA
Afya Limited, is a medical education group in Brazil. The company is headquartered in Nova Lima, Brazil.
Visit Website →Covista Inc.
CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA
Covista Inc., provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. The company is headquartered in Chicago, Illinois.
Compare with Other EDUCATION & TRAINING SERVICES Stocks
Want to dig deeper into these stocks?